Transforming Health Care Through Evidence and Collaboration
Transforming Health Care Through Evidence and Collaboration

Journalism Grants

 journalism grants image

 

NIHCM Foundation supports timely health care journalism that informs efforts to improve the health of Americans and that examines emerging health issues and their implications for cost, quality and access.

Grants provide funding for:

  • health reporting
  • educational opportunities for health care reporters
  • support for documentary films and their public engagement campaigns

 

View All Journalism Grantees View Research Grants

 

Application Information

We are no longer accepting letters of inquiry for the 2019-2020 round of grant making. NIHCM will notify grant winners in November 2019, for project start dates as early as January 2020.

Journalism Grantee News

site masthead logo dark2x
New Article Explores How Drugmakers Promote Prescribing
Milwaukee Journal Sentinel
The third piece in a series on autoimmune drugs, this story investigated how spending by pharmaceutical companies promotes prescribing of their drugs through marketing to doctors and direct-to-consumer advertising, even when there may be more clinically appropriate or cost-effective options.

site masthead logo dark2x
New Article Highlights Risks & Rewards of Biologic Drugs
Milwaukee Journal Sentinel
The second piece in a series on aut drugs, this story shared how patients weigh the risks of side effects with the reward of a heightened quality of life due to relief from the symptoms of autoimmune diseases.

newshour logo hiresNew Series on the Pandemic Threat
PBS NewsHour
Flu kills thousands of people in the U.S. each year, and there is always a risk that a new virus strain emerges and causes a pandemic. This three-part series explored the origins of flu pandemics in recent history and the challenges of preparing for and responding to deadly outbreaks.

site masthead logo dark2x
New Article on Safety Issues with Biologic Drugs
Milwaukee Journal Sentinel
Part of a new series investigating adverse events from drugs designed to treat autoimmune diseases, this story examined how biologic drugs can leave patients more susceptible to infections and side effects, sometimes with fatal results.

Alliance
Webinar Video on Prescription Drug Patents
Alliance for Health Policy
Manufacturer practices under the current patent system have come under scrutiny for blocking or delaying the entry of generic or biosimilar drugs into the market. During this webinar, panelists explored the relationship between patents, prices and patient access.